Short Interest in Nexien BioPharma, Inc. (OTCMKTS:NXEN) Drops By 25.0%

Nexien BioPharma, Inc. (OTCMKTS:NXEN) was the target of a large decline in short interest during the month of September. As of September 30th, there was short interest totalling 600 shares, a decline of 25.0% from the September 15th total of 800 shares. Based on an average daily volume of 20,500 shares, the short-interest ratio is presently 0.0 days.

Nexien BioPharma Stock Performance

Shares of OTCMKTS:NXEN opened at $0.02 on Tuesday. The stock has a market capitalization of $1.36 million, a PE ratio of -1.93 and a beta of 0.98. Nexien BioPharma has a 1 year low of $0.01 and a 1 year high of $0.04. The firm has a fifty day moving average price of $0.02 and a 200 day moving average price of $0.02.

About Nexien BioPharma

Nexien BioPharma, Inc focuses on the formulation, development, and commercialization of cannabinoid-based pharmaceuticals, drug delivery systems, and related technologies for diseases, disorders, and medical conditions. The company was formerly known as Intiva BioPharma Inc and changed its name to Nexien BioPharma, Inc in September 2018.